WWM
GPCR icon

Wolff Wiese Magana’s Structure Therapeutics GPCR Stock Holding History

Wolff Wiese Magana’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Hold
400
– – 0.01% 350
2026
Q1 		$19.3K Hold
400
– – 0.01% 333
2025
Q4 		$27.8K Buy
400
+114
+40% +$4.66K 0.02% 278
2025
Q3 		$8.01K Hold
286
– – ﹤0.01% 494
2025
Q2 		$5.93K Buy
286
+152
+113% +$3.34K ﹤0.01% 525
2025
Q1 		$2.32K Buy
+134
New +$3.28K ﹤0.01% 709

Other funds holding GPCR

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

Wolff Wiese Magana's GPCR Position: Q2 2026 in Review

Wolff Wiese Magana held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 400 shares worth $21.5K. The position accounts for 0.01% of the portfolio, ranked #350.

Wolff Wiese Magana first reported a position in GPCR in Q1 2025 and has held it in 6 quarters since. The position peaked at $27.8K in Q4 2025. 9 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Wolff Wiese Magana held 400 shares of Structure Therapeutics worth $21.5K as of Q2 2026.
  • Wolff Wiese Magana left its Structure Therapeutics share count unchanged in Q2 2026.
  • Structure Therapeutics made up 0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #350 holding.
  • Wolff Wiese Magana first reported a position in Structure Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Wolff Wiese Magana's Structure Therapeutics position peaked at $27.8K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.